drugset / Trial / NCT00592969
Efficacy and Safety of Metformin Plus Biphasic Insulin Aspart 30 in Type 2 Diabetes
RandomizedParallel-groupOpen-labelTreatment
Summary
This trial is conducted in South America. The aim of this trial is to evaluate the efficacy of metformin plus biphasic insulin aspart or insulin NPH on blood glucose control in subjects with type 2 diabetes.
Timeline
- Start
- 2003-12-03
- Primary completion
- 2004-11-02
- Completion
- 2004-11-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | biphasic insulin aspart | Protein / enzyme biologic | — | — |
| Background | Metformin | Small molecule | — | — |